BackAstrazeneca plc Overview

Astrazeneca plc Receivables

Astrazeneca plc's receivables is $15B.

Get informed when a big investor buys or sells

+ Follow
Receivables
$15.18B

Peer trimmed avg / median

Loading

Astrazeneca plc Receivables History

Loading

Astrazeneca plc vs. peers: Receivables Comparison

Loading

Astrazeneca plc Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Astrazeneca plc (AZN) FAQ

As of the most recent data (December 2025), AZN shows a receivables of $15B. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AZN's receivables is now $15B (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Astrazeneca plc is outperforming or lagging.

Tracking AZN's receivables over time shows whether Astrazeneca plc is scaling, shrinking, or reshaping that part of the business. The current reading is $15B In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Astrazeneca plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $15B) with ownership activity and broader fundamentals.

Astrazeneca plc's receivables is $15B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.